BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26921756)

  • 1. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
    Gao YZ; Zhao LF; Ma J; Xue WH; Zhao H
    Eur J Pharmacol; 2016 Jun; 780():8-15. PubMed ID: 26921756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Pan CW; Pan ZZ; Hu JJ; Chen WL; Zhou GY; Lin W; Jin LX; Xu CL
    Eur J Pharmacol; 2016 Jan; 770():85-91. PubMed ID: 26668000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
    Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
    Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Tian Y; Li Z; Shen B; Zhang Q; Feng H
    Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
    Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
    Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
    Kim SJ; Lee SM
    Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation.
    Xie YL; Chu JG; Jian XM; Dong JZ; Wang LP; Li GX; Yang NB
    Biomed Pharmacother; 2017 Jul; 91():70-77. PubMed ID: 28448872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
    Huang H; Zhang X; Li J
    J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
    Wu YL; Lian LH; Wan Y; Nan JX
    Chem Biol Interact; 2010 Dec; 188(3):526-34. PubMed ID: 20850421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betulin inhibits lipopolysaccharide/D-galactosamine-induced acute liver injury in mice through activating PPAR-γ.
    Xu GM; Zan T; Li HY; Han JF; Liu ZM; Huang J; Dong LH; Zhang HN
    Biomed Pharmacother; 2018 Oct; 106():941-945. PubMed ID: 30119266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
    Zhu Y; Chen X; Rao X; Zheng C; Peng X
    Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
    Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y
    J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
    Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of protostemonine on LPS/GalN-induced acute liver failure: Roles of increased hepatic expression of heme oxygenase-1.
    Cheng Z; Yue L; Zhao W; Yang X; Shu G
    Int Immunopharmacol; 2015 Dec; 29(2):798-807. PubMed ID: 26363973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
    Li J; Zhang X; Huang H
    Int Immunopharmacol; 2014 Dec; 23(2):523-9. PubMed ID: 25311666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl 3,4-dihydroxybenzoate protects against d-galN/LPS-induced acute liver injury by inhibiting inflammation and apoptosis in mice.
    Wang X; Wu L; Zhang Q; Li L; Xie Y; Wan X; Wu H; Xiang Y
    J Pharm Pharmacol; 2019 Jul; 71(7):1082-1088. PubMed ID: 31032922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.